USEFULNESS OF URINARY BIOCHEMISTRY IN THE FOLLOW-UP OF PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 3B-5NOD

被引:0
|
作者
Alcazar Arroyo, Roberto [1 ]
Martin Navarro, Juan Antonio [1 ]
Rubio Menendez, Veronica [1 ]
Barba Teba, Raquel [1 ]
Medina, Laura [1 ]
Procaccini, Fabio [1 ]
Puerta Carretero, Marta [1 ]
Ortega Diaz, Mayra [1 ]
Lucena Valverde, Rafael [1 ]
Jaldo Rodriguez, Maria Teresa [1 ]
De Sequera Ortiz, Patricia [1 ]
机构
[1] Hosp Univ Infanta Leonor, Nephrol, Madrid, Spain
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
5565
引用
收藏
页码:I587 / I588
页数:2
相关论文
共 50 条
  • [21] Elderly patients with chronic kidney disease: What happens after 24 months of follow-up
    Heras, M.
    Fernandez-Reyes, M. J.
    Guerrero, M. T.
    Sanchez, R.
    Munoz, A.
    Macias, M. C.
    Molina, A.
    Prado, F.
    Alvarez-Ude, F.
    NEFROLOGIA, 2009, 29 (04): : 343 - 349
  • [22] Long term follow up of infants with severe chronic kidney disease: 20 years follow-up
    Mekahli, D.
    Ledermann, S.
    Rees, L.
    PEDIATRIC NEPHROLOGY, 2009, 24 (04) : 917 - 917
  • [23] Bone health in children with chronic kidney disease - A 3-year follow-up study
    Swolin-Eide, D.
    Magnusson, P.
    Hansson, S.
    BONE, 2007, 40 (06) : S79 - S80
  • [24] Nutritional Predictors of Mortality after 10 Years of Follow-Up in Patients with Chronic Kidney Disease at a Multidisciplinary Unit of Advanced Chronic Kidney Disease
    Barril, Guillermina
    Nogueira, Angel
    Alvarez-Garcia, Graciela
    Nunez, Almudena
    Sanchez-Gonzalez, Carmen
    Ruperto, Mar
    NUTRIENTS, 2022, 14 (18)
  • [25] Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up
    Iddo Z. Ben-Dov
    Yonatan Oster
    Keren Tzukert
    Talia Alster
    Raneem Bader
    Ruth Israeli
    Haya Asayag
    Michal Aharon
    Ido Burstein
    Hadas Pri-Chen
    Ashraf Imam
    Roy Abel
    Irit Mor-Yosef Levi
    Abed Khalaileh
    Esther Oiknine-Djian
    Aharon Bloch
    Dana G. Wolf
    Michal Dranitzki Elhalel
    Journal of Nephrology, 2022, 35 : 153 - 164
  • [26] Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
    Gustavo Lenci Marques
    Shirley Hayashi
    Anna Bjällmark
    Matilda Larsson
    Miguel Riella
    Marcia Olandoski
    Bengt Lindholm
    Marcelo Mazza Nascimento
    Scientific Reports, 11
  • [27] FOLLOW-UP REGISTERS FOR CHRONIC DISEASE - 10 YEARS EXPERIENCE WITH A FOLLOW-UP SYSTEM FOR THYROID PATIENTS
    JONES, SJ
    PEARSON, JCG
    HEDLEY, AJ
    BEWSHER, PD
    WEIR, RD
    CROOKS, J
    MACPHERSON, JN
    DINWOODIE, DL
    ALEXANDER, WD
    YOUNG, RE
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1980, 34 (02) : 154 - 154
  • [28] Longitudinal Follow-up of Older Adults with Sickle Cell Disease and Chronic Kidney Disease
    Doyle, A.
    Khan, A.
    Kesse-Adu, R.
    Breen, C.
    Howard, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 31 - 32
  • [29] Guidelines for the follow-up of pediatric patients with chronic liver disease
    Afazani, Adriana
    Boldrini, Gustavo
    Ciocca, Mirta
    Costaguta, Alejandro
    Cuarterolo, Miriam
    DAgostino, Daniel
    D'Alia, Patricia
    Lopez, Susana
    Malla, Ivonne
    Perez Carusi, Rosana
    Ramonet, Margarita
    Camila Sanchez, M.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2022, 120 (01): : S19 - S61
  • [30] Similar Quality in Chronic Kidney Disease Multidisciplinary Follow-Up between Kidney Transplant and Pre-Dialysis Patients
    Carminatti, M.
    Fernandes, N. M.
    Colugnati, F. A.
    Sanders-Pinheiro, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 959 - 960